My ePortfolio Register   

Clinical advances in treating colorectal cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.09.17
Views: 843

Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany

Prof Geißler speaks with ecancer at ESMO 2017 about recent trials in treating colorectal cancer presented at the congress.

He notes the Prodige 18 trial of bevacizumab and the Tricolore trial of combination therapy as stand-out presentations.

Prof Geißler also spoke about his work in the VOLFI trial of triplet therapy for CRC, here.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence